Skip to main content

Month: August 2023

Antipsychotic Drugs Market Size to Surpass USD 24.35 Billion in 2030, exhibiting a CAGR of 6.0%

As per the report by Fortune Business Insights, the global Antipsychotic Drugs Market size is projected to reach USD 24.35 billion in 2030, at a CAGR of 6.0% during the forecast period, 2023-2030 Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Antipsychotic Drugs Market Size was valued at USD 15.47 billion in 2022 and is projected to grow from USD 16.14 billion in 2023 to USD 24.35 billion by 2030, exhibiting a CAGR of 6.0% during the forecast period. Psychiatric illness includes mental diseases symptoms of psychosis such as schizophrenia, bipolar disorder, and depression. Growing demand for the medications for these is attributed to the increased prevalence of schizophrenia and bipolar disorder. This information is provided by Fortune Business Insights™ in its research report...

Continue reading

AI Governance Market Size to Surpass USD 1,434,786 thousand by 2030, exhibiting a CAGR of 41.6%

As per the report by Fortune Business Insights, the global AI governance market size is projected to reach USD 1,434,786 thousand in 2030, at a CAGR of 41.6% during the forecast period, 2023-2030. Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global AI governance market size was valued at USD 89,900 thousand in 2022 and is projected to grow from USD 125,886 thousand in 2023 to USD 1,434,786 thousand by 2030, exhibiting a CAGR of 41.6% during the forecast period. Increasing Need for Transparency and Trust Building in AI Technologies to Drive Market Growth. Fortune Business Insights presents this information in their report titled “Global AI Governance Market Forecast, 2023-2030.”Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ai-governance-market-105975AI...

Continue reading

Behavior Analytics Market Size to Surpass USD 7384.4 Million by 2030, exhibiting a CAGR of 37.3%

As per the report by Fortune Business Insights, the global behavior analytics market size is projected to reach USD 7384.4 Million in 2030, at a CAGR of 37.3% during the forecast period, 2023-2030. Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global behavior analytics market size was valued at USD 586.5 million in 2022 and is projected to grow from USD 801.8 million in 2023 to USD 7384.4 million by 2030, exhibiting a CAGR of 37.3% during the forecast period. Leveraging analytical tools for market insights and enhanced security to rapidly transform industries. Fortune Business Insights presents this information in their report titled “Global Behavior Analytics Market Forecast, 2023-2030.”Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/behavior-analytics-market-107862Behavior...

Continue reading

Solar Panel Market Size [2023-2030] | Industry Share, Growth, Price and Trends Forecast Report

Solar Panel Market: Increasing Demand for Alternate Energy Sources for Use in Various Applications Worldwide to Aid in Expansion of Market Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — The global solar panel market size is anticipated to rise progressively on account of the increasing demand for power from commercial, residential, and industrial sectors. Solar energy is one of the  significant sources of renewable energy and is responsible for majorly impacting the market growth. Solar panels are used to convert light derived from the sun into electricity for utilization in electrical power loads serving various residential, commercial, and industrial purposes. More information on the market is provided in a recently published report by Fortune Business insights™ titled, “Solar Panel Market Size, Share & Industry Analysis,...

Continue reading

Self-Service BI Market Size to Surpass USD 20.22 Billion by 2030, exhibiting a CAGR of 19.8%

As per the report by Fortune Business Insights, the global Self-Service BI Market size is projected to reach USD 20.22 Billion by 2030, at a CAGR of 19.8% during the forecast period. Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global self-service BI market size was valued at USD 4.88 billion in 2022 and is projected to grow from USD 5.71 billion in 2023 to USD 20.22 billion by 2030, exhibiting a CAGR of 19.8% during the forecast period. Rise in the Investments in the Self-Service Analytics to Aid Market Development. Fortune Business Insights™ shares this information in its report titled “Self-Service BI Market Forecast, 2023-2030” Self-service BI helps in developing new strategies which helps management and businesses. Rise in the investments in the self-service analytics...

Continue reading

Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

On track to present initial data from Phase 1/2 clinical trial of MRT-2359 for MYC-driven solid tumors in the second half of 2023 Received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for MRT-2359 for the treatment of small cell lung cancer (SCLC) Announced development candidate MRT-6160, a novel, highly selective molecular glue degrader of VAV1, with IND submission expected 1H 2024 Strong cash position expected to sustain operations into 2025 and enable advancement of pipeline of novel molecular glue degradersBOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today reported business highlights and financial results for the quarter ended June 30, 2023. “During...

Continue reading

WiGig Market Size to Surpass USD 81.45 Billion by 2030, at a CAGR of 22.5%

As per the report by Fortune Business Insights, the global WiGig Market Size is projected to reach USD 81.45 billion by 2030, at a CAGR of 22.5% during the forecast period. Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global WiGig Market Size was valued at USD 16.29 billion in 2022 and is projected to grow from USD 19.71 billion in 2023 to USD 81.45 billion by 2030, exhibiting a CAGR of 22.5% during the forecast period. Wireless Gigabit Market Thrives on High-Speed Connectivity Demands. Fortune Business Insights presents this information in their report titled “Global WiGig Market Forecast, 2023-2030.” The wireless gigabit market is experiencing growth driven by factors such as the rising demand for high-speed internet connectivity, increased adoption of consumer electronics, and the...

Continue reading

Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

– Phase 1/1b clinical trial for IL-2 INDUKINE™ WTX-124 progressing in patients with advanced or metastatic solid tumors; initial first-in-human clinical data from monotherapy dose-escalation arm expected in 4Q 2023 – – Phase 1 clinical trial for IL-12 INDUKINE WTX-330 progressing in patients with advanced or metastatic solid tumors or lymphoma – WATERTOWN, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today provided a business update and reported financial results for the second quarter ended June 30, 2023. “Throughout the second quarter, we have continued...

Continue reading

Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

– Continued Progress in Expanding and Advancing Clinical Pipeline –– Conference Call Today at 8:30 a.m. ET – ATLANTA, Aug. 10, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID, today announced financial results for the second quarter ended June 30, 2023 and provided a corporate update. Key Highlights and Upcoming MilestonesThe Company announced that the Food & Drug Administration (“FDA”) communicated that, following their initial review of the Company’s chronic toxicology program, the program’s studies appear adequate to support the safety of IMC-1 at the dose proposed by the Company for chronic...

Continue reading

HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line setting for advanced head and neck cancer Recruitment ongoing for two Phase 1 clinical trials (HB-300 for advanced prostate cancer and Gilead-partnered HB-400 for chronic hepatitis B) IND-enabling activities in progress to advance two additional therapeutics into the clinic in 2024 (Gilead-partnered HB-500 for HIV and Roche-partnered HB-700 for KRAS-mutated cancers) $50 million follow-on offering strengthened cash basis to support initiation of randomized study of HB-200 in combination with pembrolizumab in H1 2024NEW YORK and VIENNA, Austria, Aug. 10, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.